FDA approval normally follows a formal application supported by adequate evidence for a defined product, dose, route, patient population, manufacturing process, labeling, effectiveness, and safety profile
Morgan PT, Breen L
What Patients Actually Report Anecdotally (and I want to underscore that word), compounding pharmacy practice sees: Reduced gut symptoms within 3 to 6 weeks for a meaningful subset of patients Improved tolerance to previously reactive foods in some cases, though this is highly variable and unpredictable Stable symptom maintenance in patients with already-controlled IBD Generally good tolerability with few reported adverse effects These are observational reports, not controlled-trial outcomes
Epithalon is considered a bioregulator peptide, designed to mimic and optimize the functions of the pineal gland, particularly in areas related to cellular aging and overall longevity
Clinical Update 3/11/2022 Green Tea and Colon Polyps Can taking green tea extract reduce the recurrence colon polyps